General Information of the Compound
Compound ID |
CP0103405
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole
Show/Hide
|
||||||||||||||||||
Synonyms |
3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole
3-[(4-phenylpiperazin-1-yl)methyl]-1H-indole
3-[(4-phenylpiperazino)methyl]-1h-indole
4281-72-5
AC1L5R6D
AC1Q1ILD
AKOS030540271
BDBM50050464
CBDivE_012786
CCG-45935
CHEMBL59324
CTK4I6632
KB-286915
MCULE-7772581256
MolPort-002-141-505
NSC-33115
NSC33115
Oprea1_259378
ZINC53151307
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H21N3
|
||||||||||||||||||
Molecular Weight |
291.398
|
||||||||||||||||||
Canonical SMILES |
C(N1CCN(CC1)c1ccccc1)c1c[nH]c2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H21N3/c1-2-6-17(7-3-1)22-12-10-21(11-13-22)15-16-14-20-19-9-5-4-8-18(16)19/h1-9,14,20H,10-13,15H2
Show/Hide
|
||||||||||||||||||
InChIKey |
FDOZNCJWYJMHAG-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
4281-72-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor
Clinical Information about the Compound